Literature DB >> 30396597

Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification.

Christoph F Dietrich1, Andrea Tannapfel2, Hyun-Jung Jang3, Tae Kyoung Kim3, Peter N Burns4, Yi Dong5.   

Abstract

Hepatocellular adenoma is a rare benign liver tumor. Predisposing factors include hepatic storage diseases and some genetic conditions. A new histology-based classification has been proposed but to date, the corresponding ultrasound imaging features have not been reported. Here we review the new classification scheme and discuss the corresponding features on contrast-enhanced ultrasound imaging.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Classification; Features; Guidelines; Hepatocellular adenoma; Ultrasound

Mesh:

Substances:

Year:  2018        PMID: 30396597     DOI: 10.1016/j.ultrasmedbio.2018.06.015

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  4 in total

Review 1.  [Sonographic diagnostics of liver tumors].

Authors:  C Höner Zu Siederdissen; A Potthoff
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

Review 2.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

3.  Malignant transformation of hepatic adenoma complicated by rupture and hemorrhage: An extremely rare clinical entity.

Authors:  Rishi Philip Mathew; Florin Manolea; Safwat Girgis; Vimal Patel; Gavin Low
Journal:  Intractable Rare Dis Res       Date:  2019-11

Review 4.  Multiple hepatocellular adenomas associated with long-term administration of androgenic steroids for aplastic anemia: A case report and literature review.

Authors:  Lixia Wang; Cong Wang; Wei Li; Fanyang Meng; Yuying Li; Hongqiong Fan; Yanhua Zhou; Gnana Bharathi; Sujun Gao; Yan Yang
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.